HGH Fragment 176-191: What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and HGH Fragment 176-191 is not approved for human or veterinary use.

What is HGH Fragment 176-191?

HGH Fragment 176-191 is a synthetic peptide corresponding to the C-terminal region (amino acids 176-191) of human growth hormone. It is studied in the research literature for lipid-metabolism pathways and is examined as a fragment distinct from the growth-promoting activity of the full hormone.

Where HGH Fragment 176-191 sits in the research literature

The evidence base is largely preclinical, based on cell and animal studies of fat metabolism. Research has suggested that the functional domain responsible for the antilipogenic activity of growth hormone resides in this C-terminal region. Laboratory findings should not be extrapolated to people.

Reported areas of preclinical interest

• Lipid metabolism: studied for antilipogenic and fat-metabolism effects in laboratory models.
• Growth-hormone fragment biology: examined as a C-terminal fragment separate from full growth-hormone activity.

Why the “research use only” label matters

HGH Fragment 176-191 is supplied as a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption.

Handling and storage

Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.

Frequently asked questions

What is HGH Fragment 176-191 studied for?

It is studied in laboratory models of lipid metabolism as a growth-hormone fragment.

Is HGH Fragment 176-191 approved for human use?

No. It is a research material only and is not intended for human or veterinary use.

Key takeaways

HGH Fragment 176-191 is a growth-hormone C-terminal fragment studied in preclinical lipid-metabolism research. It is a research material only. Review the HGH Fragment 176-191 research product.

References

References sourced via PubMed.

1. Wu Z, Ng FM. Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone. Biochem Mol Biol Int. 1993;30(1):187-196. PubMed 8358331.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.